Zoetis Inc.
ZTS
$77.69
-$0.58-0.74%
NYSE
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/30/2026
-
MarketBeat
5/30/2026
-
Globe Newswire
5/29/2026
-
GuruFocus
5/29/2026
-
Globe Newswire
5/29/2026
-
Business Wire
5/29/2026
-
The Cerbat Gem
5/29/2026
-
MarketBeat
5/29/2026
-
MarketBeat
5/29/2026
-
MarketBeat
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
5/29/2026
-
GuruFocus
5/29/2026
-
Globe Newswire
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
5/29/2026
-
Business Wire
5/29/2026
-
GuruFocus
5/28/2026
-
PR Newswire
5/28/2026
-
SeekingAlpha
5/28/2026
-
Seeking Alpha: Transcripts
5/28/2026
-
Business Wire
5/28/2026
-
GuruFocus
5/28/2026
-
Business Wire
5/28/2026
-
Globe Newswire
5/28/2026
-
PR Newswire
5/28/2026
-
Globe Newswire
5/28/2026
-
PR Newswire
5/28/2026
-
PR Newswire
5/28/2026
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, May 7, 2026
Period Date
Tuesday, March 31, 2026
Next Filing
Week of Aug 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
973 822 7000
Address
10 Sylvan Way
Parsippany, NJ 07054
Parsippany, NJ 07054
Country
Year Founded
Business Description
Sector
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal...
more